BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33400818)

  • 21. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases.
    Dexiang Z; Li R; Ye W; Haifu W; Yunshi Z; Qinghai Y; Shenyong Z; Bo X; Li L; Xiangou P; Haohao L; Lechi Y; Tianshu L; Jia F; Xinyu Q; Jianmin X
    Ann Surg Oncol; 2012 Sep; 19(9):2860-8. PubMed ID: 22526903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance.
    Peng S; Huang P; Yu H; Wen Y; Luo Y; Wang X; Zhou J; Qin S; Li T; Chen Y; Liu G; Huang M
    Medicine (Baltimore); 2018 Mar; 97(10):e0044. PubMed ID: 29517661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases.
    Bertsimas D; Margonis GA; Sujichantararat S; Boerner T; Ma Y; Wang J; Kamphues C; Sasaki K; Tang S; Gagniere J; Dupré A; Løes IM; Wagner D; Stasinos G; Macher-Beer A; Burkhart R; Morioka D; Imai K; Ardiles V; O'Connor JM; Pawlik TM; Poultsides G; Seeliger H; Beyer K; Kaczirek K; Kornprat P; Aucejo FN; de Santibañes E; Baba H; Endo I; Lønning PE; Kreis ME; Weiss MJ; Wolfgang CL; D'Angelica M
    JAMA Surg; 2022 Aug; 157(8):e221819. PubMed ID: 35648428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients.
    Hashimoto M; Kobayashi T; Ishiyama K; Ide K; Ohira M; Tahara H; Kuroda S; Hamaoka M; Iwako H; Okimoto M; Ohdan H
    Int J Surg; 2016 Dec; 36(Pt A):96-103. PubMed ID: 27741421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accessing new prognostic significance of preoperative carcinoembryonic antigen in colorectal cancer receiving tumor resection: More than positive and negative.
    Cai Z; Xiao J; He X; Ke J; Zou Y; Chen Y; Wu X; Li X; Wang L; Wang J; Lan P; Wu X
    Cancer Biomark; 2017; 19(2):161-168. PubMed ID: 28128739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphatic Invasion is an Independent Adverse Prognostic Factor in Patients with Colorectal Liver Metastasis.
    de Ridder JA; Knijn N; Wiering B; de Wilt JH; Nagtegaal ID
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S638-45. PubMed ID: 25986865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study.
    Beppu T; Wakabayashi G; Hasegawa K; Gotohda N; Mizuguchi T; Takahashi Y; Hirokawa F; Taniai N; Watanabe M; Katou M; Nagano H; Honda G; Baba H; Kokudo N; Konishi M; Hirata K; Yamamoto M; Uchiyama K; Uchida E; Kusachi S; Kubota K; Mori M; Takahashi K; Kikuchi K; Miyata H; Takahara T; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):711-20. PubMed ID: 25902703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of Herpesvirus Entry Mediator Expression in Human Colorectal Liver Metastasis.
    Sasaki Y; Hokuto D; Inoue T; Nomi T; Yoshikawa T; Matsuo Y; Koyama F; Sho M
    Ann Surg Oncol; 2019 Nov; 26(12):3982-3989. PubMed ID: 31313042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of carcinoembryonic antigen (CEA) density as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases.
    Huo YR; Glenn D; Liauw W; Power M; Zhao J; Morris DL
    Eur Radiol; 2017 Jan; 27(1):128-137. PubMed ID: 27165139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical outcomes and prognostic factors in patients with synchronous colorectal liver metastases.
    Fontana R; Herman P; Pugliese V; Perini MV; Coelho FF; Cecconello I
    Arq Gastroenterol; 2014; 51(1):4-9. PubMed ID: 24760056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic assessment of carcinoembryonic antigen in the first month after liver resection for colorectal liver metastases as a rapid-recurrence predictor.
    Takamoto T; Sugawara Y; Hashimoto T; Shimada K; Inoue K; Maruyama Y; Makuuchi M
    J Surg Oncol; 2016 Mar; 113(4):463-8. PubMed ID: 27100029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
    Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
    Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinoembryonic antigen half-life is an early predictor of therapeutic effects in induction chemotherapy for liver metastases from colorectal cancer.
    Nagai Y; Beppu T; Sakamoto Y; Miyamoto Y; Hayashi H; Nitta H; Imai K; Masuda T; Okabe H; Hirashima K; Imamura Y; Baba Y; Chikamoto A; Baba H
    Anticancer Res; 2014 Oct; 34(10):5529-35. PubMed ID: 25275051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Evaluation of Relapse Risk (CERR) Score for Colorectal Liver Metastases: Development and Validation.
    Chen Y; Chang W; Ren L; Chen J; Tang W; Liu T; Jian M; Liu Y; Wei Y; Xu J
    Oncologist; 2020 Jul; 25(7):e1031-e1041. PubMed ID: 32181531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinoembryonic antigen testing after curative liver resection for synchronous liver metastasis of colorectal cancer: a Japanese multicenter analysis.
    Okazaki S; Baba H; Iwata N; Yamauchi S; Sugihara K
    Surg Today; 2017 Oct; 47(10):1223-1229. PubMed ID: 28439715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
    Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
    World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CALy Prognostic Score (CEA, ALP, Lymphocyte Count) as a predictor of survival after hepatectomy for liver-only colorectal metastases.
    Neofytou K; Giakoustidis A; Mudan S
    J BUON; 2015; 20(3):746-55. PubMed ID: 26214626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.